1. Home
  2. LOOP vs MAIA Comparison

LOOP vs MAIA Comparison

Compare LOOP & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

N/A

Current Price

$0.90

Market Cap

58.1M

Sector

Industrials

ML Signal

N/A

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

N/A

Current Price

$1.16

Market Cap

44.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LOOP
MAIA
Founded
2010
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.1M
44.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
LOOP
MAIA
Price
$0.90
$1.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
94.8K
911.7K
Earning Date
01-13-2026
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,112,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,035.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10901.98
N/A
52 Week Low
$0.85
$0.87
52 Week High
$2.29
$2.74

Technical Indicators

Market Signals
Indicator
LOOP
MAIA
Relative Strength Index (RSI) 31.14 46.50
Support Level $1.02 $1.07
Resistance Level $1.07 $1.75
Average True Range (ATR) 0.06 0.17
MACD 0.00 0.01
Stochastic Oscillator 1.29 12.50

Price Performance

Historical Comparison
LOOP
MAIA

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: